The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.

An Update on the Pathophysiology and Treatment of Cardiorenal

Cardiorenal Syndrome - ScienceDirect

Cardiorenal Syndrome Journal of the American College of Cardiology

Advances in pathogenesis and current therapeutic strategies for

Edgar V. Lerma 🇵🇭 on X: 5 subtypes of #Cardiorenal syndrome

IJMS, Free Full-Text

Type 4 cardiorenal syndrome Revista Portuguesa de Cardiologia

Progress and Challenges of Understanding Cardiorenal Syndrome Type 3

Anemia of cardiorenal syndrome - Kidney International Supplements

Cardiorenal Syndrome Revisited

The cardio-renal-metabolic connection: a review of the evidence

Acute cardiorenal syndrome: Mechanisms and clinical implications

Wnt/β-catenin signaling mediates both heart and kidney injury in